Electroconvulsive Therapy

Inflammatory processes were linked to lower cognitive functioning in older patients with depression before electroconvulsive therapy, with further dysfunction during and after therapy, according to a Journal of Clinical Psychiatry study.

The continued use of electroconvulsive therapy appeared warranted for reducing suicide risk among patients with severe depression, according to results of a registry-based cohort study published in JAMA Network Open.

Electroconvulsive therapy for depression did not lead to a clinically significant increased risk for serious medical events, according to results of a propensity score-matched, retrospective cohort study published in The Lancet Psychiatry.

Sevoflurane use for electroconvulsive therapy significantly reduced seizure duration and increased maximum heart rate compared with use of intravenous anaesthetics for ECT.

Electroconvulsive therapy appeared safe and effective for treating certain severe psychiatric illnesses among children and adolescents, according to results of a retrospective cohort study published in Journal of Clinical Psychiatry.

Acute course electroconvulsive therapy benefited patients with depression with or without comorbid borderline personality disorder, according to results of a retrospective cohort study published in Journal of Clinical Psychiatry.

Electroconvulsive therapy was a significantly effective treatment option for severe depressive disorder, according to study results published in Journal of Clinical Psychiatry.

Emotional memory reactivation before electroconvulsive therapy for depression did not offer significant benefits vs. control memory reactivation, according to results of a randomized clinical trial published in JAMA Network Open.

Use of electroconvulsive therapy among older adults with depression remains rare, despite significant evidence of its efficacy, according to results of a study published in Journal of Clinical Psychiatry.

A new magnetic brain stimulation intervention reduced severe depression symptoms among 90% of participants in a study published in American Journal of Psychiatry.